Skip to content

The study is looking at whether irrigation in a joint procedure, or taking a medication by mouth, or doing both together is the best way to treat jaw joint problems.

A randomized controlled trial comparing the effectiveness of arthrocentesis alone, oral duloxetine alone, and a combination of both in the treatment of temporomandibular joint disorders. - Tmj

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/06/068839
Enrollment
21
Registered
2024-06-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K088- Other specified disorders of teethand supporting structures

Interventions

Intervention1: Oral duloxetine: All patients requiring minor oral surgical procedure having tmj pain with vas score 5 or more. Intervention2: Arthrocentesis with oral duloxetine: All patients requirin

Sponsors

Dr Damini Hiralal Nikhar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient willing to participate in study. 2.Patients in the age group of 18 -60 years. 3.Patients diagnosed with TMJ arthralgia and intra articular TMJ disorders as given by DC TMD criteria. 4.Patients with VAS score 5 or more pre-operatively

Exclusion criteria

Exclusion criteria: 1.Patients having systemic diseases in which duloxetine is contraindicated. 2.Patients with coagulation disorders. 3.Allergic reaction to local anesthetic agents and duloxetine. 4.TMJ pain following traumatic injury.

Design outcomes

Primary

MeasureTime frame
To evaluate the efficacy of arthrocentesis, oral duloxetine alone and combination of arthrocentesis with oral duloxetine in reducing pain in temporomandibular joint disorders.Timepoint: VAS score at day1, day7, 1st month, 3rd month

Secondary

MeasureTime frame
To evaluate the efficacy of arthrocentesis, oral duloxetine alone and combination of arthrocentesis with oral duloxetine in improving the maximum mouth opening in temporomandibular joint disordersTimepoint: Maximum mouth opening at day1, day7, 1st month,3rd month

Countries

India

Contacts

Public ContactDr Damini Hiralal Nikhar

Terna dental college and hospital

sanjoshi99@gmail.com9869057337

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026